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Abstract
Introduction: Primary splenic angiosarcoma is a rare neoplasm of vascular origin carrying a very
poor prognosis, partly due to its high metastatic potential. This disease presents frequently with
splenic rupture and hemorrhage. We report the case of a 17-year-old woman who presented with
rupture of a primary splenic angiosarcoma.
Case presentation: The patient presented with diffuse abdominal pain and distention. Clinical
examination revealed severe tenderness in the left upper abdominal quadrant, a palpable abdominal
mass, and hemodynamic instability with a systolic arterial blood pressure of 75 mmHg and heart
rate of 135 beats per minute. Blood tests revealed anemia (hemoglobin 7.0 g/dl) and
thrombocytopenia (platelets 70 × 109/liter). After initial fluid resuscitation and stabilization,
abdominal ultrasound and computed tomography were performed, revealing a large quantity of
intraperitoneal free fluid, an enlarged spleen, and a heterogeneous low-density signal within the
splenic parenchyma, which showed varying degrees of contrast enhancement. At laparotomy a huge
(weight 1530 g, diameter 19 cm) actively bleeding spleen was identified and splenectomy was
performed. Histopathology showed a primary splenic angiosarcoma. After an uneventful recovery,
the patient was discharged on the sixth postoperative day.
Conclusion:  Primary splenic angiosarcoma is rare. Although this malignancy is usually
encountered in advanced age, there have been a few reported cases among younger patients. The
case reported here presented with splenic rupture, was treated by laparotomy and splenectomy,
and the patient is disease free 16 months after surgery.
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Introduction
Primary angiosarcoma or hemangiosarcoma of the spleen
is an extremely rare malignancy, the pathogenesis of
which is not completely understood, with high metastatic
potential and an exceedingly poor prognosis, regardless of
the treatment regimen. This aggressive disease entity usu-
ally presents in adults in their sixth to seventh decade with
only eight cases reported in the literature in people aged
below 18 years of age. The reported median survival rates
range from 4.4 months to 14 months, depending respec-
tively on whether the diagnosis is made after splenic rup-
ture or is based on clinical findings [1,2].
These mesenchymal tumors can easily be overlooked and
splenic rupture is the most frequently encountered pre-
senting manifestation. We report a case of splenic rupture
due to angiosarcoma in a 17-year-old woman. This is the
ninth reported case of this condition in a patient aged
under 18 years of age and, to the best of the authors'
knowledge, is the second case presenting with splenic rup-
ture in this age group.
Case presentation
A 17-year-old woman presented to the emergency depart-
ment of our hospital with diffuse abdominal pain and dis-
tention. Physical examination revealed severe tenderness
in the left upper abdominal quadrant, a palpable abdom-
inal mass, and hemodynamic instability; in particular, the
patient's systolic arterial blood pressure was 75 mmHg
and her heart rate was 135 beats per minute. After initial
resuscitation with the administration of isotonic fluids,
the hemodynamic status of the patient was normalized
and further investigations were performed. Apart from
moderate weight loss and sporadic episodes of dizziness,
the reported medical history was unremarkable up to the
day before admission. Laboratory investigations revealed
anemia (hemoglobin 7.0 g/dl) and thrombocytopenia
(platelets 70 × 109/liter). An abdominal ultrasound
showed a large quantity of intraperitoneal free fluid and
an enlarged spleen. These findings were confirmed by an
abdominal computed tomography (CT) scan (Figure 1),
which further demonstrated hemorrhage originating from
the spleen and a heterogeneous, low-density signal within
the splenic parenchyma, which showed varying degrees of
contrast enhancement. Chest X-ray and CT chest scan
were normal.
Laparotomy revealed a huge, actively bleeding spleen;
more than one liter of blood had filled the intraperitoneal
cavity. No abnormal adhesions were detected between the
spleen, the diaphragm, or other organs, and macroscopic
examination of all four abdominal quadrants did not
reveal any other pathology. Splenectomy was performed
along with peritoneal lavage with warm saline to evacuate
the clots. Intraoperatively, the patient received two units
of packed red blood cells, one unit of platelets and two
units of fresh frozen plasma.
The splenic weight was 1530 g, its greatest diameter was
19 cm, and macroscopically it appeared nodular and
spongy with hemorrhagic characteristics (Figure 2A and
2B), excluding the diagnosis of idiopathic rupture. The
pathology examination of the excised spleen demon-
strated an angiosarcoma, presumably of splenic origin
(Figure 3). On immunohistochemical examination, the
resected specimen showed positive immunostaining for
CD31 and CD34. Owing to the highly metastatic poten-
tial of this malignant entity, and in addition to the nega-
tive macroscopic abdominal examination, a further CT
scan of the abdomen, pelvis, and chest was performed
with no evidence of metastatic foci.
After an uneventful recovery, the patient was discharged
on the sixth postoperative day. The patient remains symp-
tom and disease free after a follow-up period of 16
months, in contrast to the median survival of 4.4 months
of patients with primary angiosarcoma of the spleen and
associated splenic rupture [2].
Discussion
Angiosarcoma originating from the spleen is a very rare
mesenchymal malignant tumor of vascular origin, con-
sisting of atypical and anaplastic endothelial cell concen-
trations. Other primary foci include the skin, soft tissues,
breast and bone marrow. Its main histological feature is
Abdominal computed tomography scan demonstrating intra- peritoneal free fluid (arrowhead) and an enlarged, anechoic  spleen with hypoechoic areas representing focal necrosis  (arrow) Figure 1
Abdominal computed tomography scan demonstrating intra-
peritoneal free fluid (arrowhead) and an enlarged, anechoic 
spleen with hypoechoic areas representing focal necrosis 
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vascular channel formation with a sarcomatous stroma
and papillary appearance due to endothelial cell prolifer-
ation, although an undifferentiated neoplasm is also a
typical finding. Angiosarcoma is the most common of the
primary malignant splenic tumors, which affect 0.14 to
0.25 per million people. This neoplasm shows a slight
male predominance, with no predilection for race, geo-
graphic location or inheritability [3]. Overall, since 1879
when Langhans described the first case of angiosarcoma
of the spleen, there have been approximately 200 cases
reported in the literature. Splenic angiosarcoma is a dis-
ease of adulthood, with a mean age of presentation at 50
to 60 years among the various series, although the pediat-
ric population may be also affected at virtually any age
[4,5].
Although the natural history of this tumor is not clear,
ionizing radiation, arsenic, vinyl chloride and chemother-
apy for lymphoma have been implicated as causative fac-
tors, and it has been reported that the pathogenesis of
splenic angiosarcoma requires the existence of a benign
pathology such as a hemangioma or hemangioendotheli-
oma. Recently, a case of angiosarcoma of the splenic cap-
sule was reported and correlated with inert foreign body
tumorigenesis [6]. There was no evidence of any of these
factors in our case. This tumor has a high incidence of
early metastasis as reflected in the reported rates of
between 69% and 100% among various series, with the
most common sites being the liver, lungs, bones or bone
marrow, lymph nodes, gastrointestinal tract, brain and
adrenal glands. Furthermore, synchronous malignancies
of the breast, colon, skin and kidney have been reported.
Our patient, however, did not show any evidence of either
metastatic or synchronous disease and this is in accord-
ance with the fact that younger patients usually present
with a single focus of malignancy.
The clinical manifestations of primary splenic angiosar-
coma range from asymptomatic disease to splenic rupture
and lethal hemorrhage. Non-specific symptoms such as
left upper abdominal discomfort, dizziness and weight
loss, as well as signs such as thrombocytopenia and an
enlarged spleen, which is present in more than of 50% of
cases, are not diagnostic and may be easily associated with
other pathologic conditions. Anemia, present in 70% of
cases, may be of normocytic, schistocytic or megaloblastic
A – Excision specimen of the enlarged spleen Figure 2
A – Excision specimen of the enlarged spleen. B – Hemor-
rhagic and nodular lesions excluded the diagnosis of idio-
pathic rupture and prompted further abdominal exploration 
for other pathologies.
Histopathological findings of angiosarcoma of the spleen Figure 3
Histopathological findings of angiosarcoma of the spleen. 
Spindle-cell neoplasm has replaced the normal red and white 
pulp in the spleen whereas ectatic vascular spaces lined with 
hypertrophied endothelial cells are apparent. Hematoxylin 
and eosin stain ×80.Journal of Medical Case Reports 2008, 2:133 http://www.jmedicalcasereports.com/content/2/1/133
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type. Splenic rupture occurs in 13% to 32% of patients,
and is the presenting and most serious manifestation in
the majority of cases. It is the worst prognostic factor for
survival, because it puts patients at increased risk of peri-
toneal dissemination with direct implantation of neoplas-
tic tissue or vascular access and hematogenous spread.
This finding is verified by the fact that splenectomy before
rupture of the organ is accompanied by better survival
rates [2]. Other independent prognostic factors include
mitotic counts, tumor size and mode of treatment [7] as
well as the thick capsule of the tumor [8].
Splenic rupture represents a serious complication, fre-
quently encountered in patients with angiosarcoma of the
spleen, and results in a fatal outcome in a significant pro-
portion of cases. The presence of consumption coagulop-
athy with profound fibrinogenopenia and
thrombocytopenia may lead to the development of dis-
seminated intravascular coagulation, characterized by a
lack of systemic fibrinolysis activation and profuse intra-
peritoneal hemorrhage, further decreasing survival rates
[9].
Imaging modalities are invaluable for the differential
diagnosis between other benign and malignant splenic
tumors, although diagnostic accuracy is lacking. CT scans
may reveal an enlarged spleen with hypo- or hyperattenu-
ating areas on nonenhanced scans. Areas of hyperattenu-
ation are likely to reflect acute hemorrhage or
hemosiderin deposits. Contrast enhancement may be
similar to that of a hepatic cavernous hemangioma,
although the pattern of enhancement is variable. On con-
trast-enhanced scans, there may be peripheral or heteroge-
neous contrast enhancement. On MRI, ill-defined
nodular lesions with low- or high-signal intensity may be
seen on both T1- and T2-weighted images depending on
the age of blood products and the presence of necrosis.
High-signal intensity is related to subacute hemorrhage or
tumor necrosis and low-signal intensity is related to
chronic hemorrhage or fibrosis in the tumor. Massive
splenic calcifications on CT scan or MRI have been
reported as a prominent suggestive finding of angiosar-
coma [10]; however, calcifications may also be found in
patients with benign lesions such as a hemangioma [11].
Conclusion
Splenic angiosarcoma, although rare, must be considered
in the differential diagnosis of patients with hematologic
abnormalities of unexplained origin and parenchymal
lesions on spleen imaging. Definitive diagnosis requires
laparotomy and splenectomy, since the risk of splenic
rupture is enhanced with percutaneous splenic biopsies.
Since metastatic disease is encountered in the majority of
cases in patients with splenic angiosarcoma, the surgical
approach with splenectomy is a more diagnostic than
therapeutic modality. Although no effective chemothera-
peutic protocol for angiosarcoma has yet been estab-
lished, combined treatment with cyclophosphamide,
adriamycin, vincristine and prednisone or other agents
after splenectomy has been employed in a few cases, with
fewer relatively good results [12]. As there was no evi-
dence of metastatic disease, our patient was not treated
with adjuvant chemotherapy; excellent results at 16
months of follow-up support this decision.
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